Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

HPV vaccination

Boots launches HPV vaccination for boys and men

Boots is extending its private human papillomavirus (HPV) vaccination service to make it available to boys and men aged 12–44 years.

The service, available at 68 Boots stores, uses the nine-valent HPV vaccine administered by a specially trained pharmacist.

“We are delighted to be able to extend our HPV vaccination service, ensuring more men and boys across the UK have access to this important vaccination,” says Richard Bradley, pharmacy director of Boots UK. “This is a fantastic example of how community pharmacists can use their clinical skills to support patients’ health in locations and at times that are convenient to them.”

The service costs £150 per vaccination and children aged 12–14 years require two vaccinations, while those aged 15–44 years require a course of three.

It protects against nine strains of HPV, which together account for 90% of HPV-related anal cancers and genital warts in both men and women. The HPV virus is also linked to penile, and head and neck, cancers, although there is a lack of data to show the effectiveness of HPV vaccination in preventing these types of cancer.

HPV vaccination has routinely been made available to girls aged 12–13 on the NHS for protection against cervical cancer. Public Health England is currently running a pilot of the vaccination for men who have sex with men, and says it has been asked by the Joint Committee for Vaccination and Immunisation to look at the impact of extending the HPV vaccination programme to adolescent boys.

HPV Action, a collaborative partnership of 45 patient and professional organisations working to reduce the health burden of HPV, is campaigning to have the NHS HPV vaccination programme extended to teenaged boys. “Without this, almost 400,000 more boys each year are being left at risk from HPV-related cancers,” says their campaign director, Peter Baker.

“In the meantime, it’s important that parents and carers who want their sons to be vaccinated have the option of taking them to organisations like Boots UK.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202616

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Young boy receives HPV vaccine

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.